Sarcopenia en enfermedad pulmonar obstructiva crónica: rehabilitación pulmonar como factor fundamental en el tratamiento multidimensional de los adultos mayores
Sarcopenia in COPD: pulmonary rehabilitation as a fundamental factor in multidimensional treatment
Número
Sección
Clubes de revista
Cómo citar
Sarcopenia en enfermedad pulmonar obstructiva crónica: rehabilitación pulmonar como factor fundamental en el tratamiento multidimensional de los adultos mayores.
rev. colomb. neumol. [Internet]. 2016 Jul. 4 [cited 2024 Dec. 22];27(2). Disponible en: https://doi.org/10.30789/rcneumologia.v27.n2.2015.34
Dimensions
Licencia
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Mostrar biografía de los autores
Visitas del artículo 406 | Visitas PDF 1096
Descargas
Los datos de descarga todavía no están disponibles.
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing. 2010;39:412-23.
- Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70:213-8.
- Goldstein G, Shelly C. Does the right hemisphere age more rapidly than the left? J Clin Neuropsychol. 1981;3:65-78.
- Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Resp Crit Care Med. 1995;152:1268-74.
- Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. The Cochrane database of systematic reviews. 2002:Cd003793.
- Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10:2807-13.
- Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respiratory Med. 2000;94:859-67.
- Samper-Ternet R, Reyes-Ortiz C, Ottenbacherc K, Cano C. Frailty and Sarcopenia in Colombia: Results from the SABE Bogotá Study 2014.
- Marcell TJ. Sarcopenia: causes, consequences, and preventions. JGerontolA BiolSciMedSci. 2003;58:M911-M6.
- Rosenberg IH. Sarcopenia: origins and clinical relevance. Clin Geriatr Med. 2011;27:337-9.
- Rolland Y, Czerwinski S, Abellan VK, Morley JE, Cesari M, Onder G,
- et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J NutrHealth Aging. 2008;12:433-50.
- Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax.
- ;62:944-9.
- Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 995;151:374-7.